Active Cells, Biochemistry & Physiology Genetics & Molecular Biology

Molecular Mechanisms of Cell Death.

In plain English

AI plain-English summary

Cells in the body commit suicide on a precise schedule, and when that schedule goes wrong, tissues either accumulate too many cells—as in cancer—or lose too many, as in neurodegenerative disease. This research tackles a fundamental gap in knowledge: how cells decide whether to die by apoptosis (the orderly, programmed death) or by necroptosis (a more recently discovered, inflammatory form of death). Many existing drugs, including chemotherapies, trigger these death pathways as a side effect, causing toxicity in healthy tissues like the heart or liver. Without a clear understanding of the molecular switches involved, drug developers cannot predict which patients will suffer harm or how to design safer treatments. The project aims to map the core proteins and pathways that govern these two death modes in normal and diseased cells. If successful, it will produce predictive models of mitochondrial toxicity—a common reason drugs fail in trials or are withdrawn after approval. This would allow pharmaceutical companies to screen out dangerous compounds earlier, and could also point to ways to reduce the toxic side effects of current treatments. This is fundamental science. It does not promise an immediate new drug. But understanding the basic mechanics of cell death has, in the past, led directly to therapies such as targeted cancer drugs that switch cell death back on in tumours.

View original technical description
Diseases such as cancer and neurodegenerative disorders are characterised by a significant alteration in the total number of cells within the tissue. This may result from increased division of cells and/or may arise from a defect in cell death regulation. In tissues such as the lymphoid system cell death is important as it controls the total number of cells, whereas in the nervous system inappropriate cell death is catastrophic. Consequently, cell death in these situations is tightly controlled and often occurs in an ordered manner by a process called ‘apoptosis’, or a more recently identified mode of cell death termed ‘necroptosis’. We are studying these cell death processes because adverse outcomes (toxicity) associated with therapeutic drugs are often mediated by the proteins/pathways that control cell death, whereas to successfully treat some diseases (e.g. cancer) it is important we find ways to switch ‘ON’ cell death. However, it is crucial to first understand the basic mechanisms that regulate cell death in order to identify ways to leave most healthy cells unharmed. We are therefore trying to uncover the fundamental mechanisms that regulate the response of normal and/or target cells to therapeutic agents, as this will help in establishing the ideal choice of agents for the treatment of disease. Our aim is to establish better predictive models of mitochondrial toxicity, providing mechanistic frameworks to facilitate safer drug development and potentially alleviate the toxic effects of existing treatments.

View the original record at the funder ↗

Researchers

Marion MacFarlane (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

Molecular Mechanisms of Cell Death
Tumour cell death and its fundamental role in establishing a pro-tumourigenic microenvironment
Regulation of apoptosis in response to anti-mitotic drugs
Regulation of Caspase Activation
Cellular and molecular mechanisms of macrophage-mediated neuroprotection

Original classification

Intramural

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.